Aveo Pharmaceuticals, Inc.
AVEODelisted Jan 19, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001325879
Aveo Pharmaceuticals, Inc. was delisted on Jan 19, 2023; its insiders filed their last Form 4 on Jan 19, 2023; 110 institutions reported holding it in 13F filings for Q4 2022, worth $367.6M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Aveo Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 57 | 1 | 55 | −1 |
| Shares | 14.1M | 47.2K | 15.4M | +1.33M (+9.5%) |
| Value | $79.0M | $264.0K | $101.2M | +$22.4M (+28.5%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Aveo Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rubric Capital Management LP | 923,885 | $6.06M | 0.32% |
| EcoR1 Capital, LLC | 647,489 | $4.25M | 0.15% |
| EAM Investors, LLC | 186,202 | $1.22M | 0.30% |
| Ameriprise Financial Inc | 162,400 | $1.06M | 0.00% |
| Bridgeway Capital Management, LLC | 53,000 | $348.0K | 0.01% |
| Gsa Capital Partners LLP | 33,410 | $219.0K | 0.03% |
| Jump Financial, LLC | 30,568 | $201.0K | 0.01% |
| Qube Research & Technologies Ltd | 18,750 | $123.0K | 0.00% |
Sold out (9)
Institutions that held Aveo Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Opaleye Management Inc. | 240,000 | $1.34M |
| Susquehanna International Group, LLP | 198,953 | $1.11M |
| Simplex Trading, LLC | 70,693 | $395.0K |
| Baird Financial Group, Inc. | 57,283 | $320.0K |
| Alps Advisors Inc | 35,325 | $197.0K |
| Jane Street Group, LLC | 13,228 | $74.0K |
| Marshall Wace, LLP | 11,021 | $62.0K |
| ExodusPoint Capital Management, LP | 11,044 | $62.0K |
| PDT Partners, LLC | 10,866 | $61.0K |
Not filed for Q2 2022 yet (1)
Institutions that held Aveo Pharmaceuticals, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna Fundamental Investments, LLC | 47,186 | $264.0K |